A recent study demonstrated that PARP inhibitors lead to increased oxidative stress in cancer cells and may enhance their sensitivity of cancer cells to hydrogen peroxide (H2O2), leading to increased cytotoxicity, inhibition of PARP, and triggering oxidative DNA damage in neoplastic cells [43]. This evidence concerns the gene PARP1 and cancer.